Nolan Sean P. insider trades
Nolan Sean P. has filed 13 Form 4s with the SEC that we hold, for Taysha Gene Therapies, Inc. (TSHA) (Chief Executive Officer, Director) and Ventas, Inc. (VTR) (Director). Across all of them we count 5 purchases worth $404.6K and 2 sales worth $840.2K reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($840.2K). The largest single trade was a sale of 136,789 shares of Taysha Gene Therapies, Inc. worth $649.7K, dated 2026-01-23. The first filing on our record is dated 2022-04-29 and the latest 2026-05-15.
Taysha Gene Therapies, Inc. (TSHA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-16 | P, purchase reported on Form 4 | 444,444 | $400.0K | 2023-08-16 |
| 2026-01-23 | S, sale reported on Form 4 | 136,789 | $649.7K | 2026-01-27 |
| 2026-01-26 | S, sale reported on Form 4 | 41,312 | $190.4K | 2026-01-27 |
Ventas, Inc. (VTR)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2020-04-20 | P, purchase reported on Form 4 | 50 | $1.4K | 2026-02-17 |
| 2020-04-20 | P, purchase reported on Form 4 | 36 | $997 | 2026-02-17 |
| 2020-07-21 | P, purchase reported on Form 4 | 27 | $924 | 2026-02-17 |
| 2020-07-21 | P, purchase reported on Form 4 | 37 | $1.3K | 2026-02-17 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1569926) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms